Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
NCT ID:
NCT00142168
Brief Title:
CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia
Official Title:
Phase II Study of CC-5103 and Rituximab in Waldenstrom's Macroglobulinemia
Study:
NCT00142168
Protocol Section:
NCT00142168